154 related articles for article (PubMed ID: 1795560)
41. Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix.
Lehtovirta P; Viinikka L; Ylikorkala O
Gynecol Oncol; 1990 May; 37(2):276-8. PubMed ID: 2344974
[TBL] [Abstract][Full Text] [Related]
42. [Immunohistochemical localization of keratin and secretory component in carcinoma of the uterine cervix].
Toki T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):359-64. PubMed ID: 2580030
[TBL] [Abstract][Full Text] [Related]
43. [Value of the assay of squamous cell carcinoma in cancer of the uterine cervix].
Gosselin P; Cazin JL; Dehaut JP; Sulman C; Baranzelli MC; Demaille MC
Presse Med; 1987 Oct; 16(34):1677-9. PubMed ID: 2959941
[TBL] [Abstract][Full Text] [Related]
44. [Establishment and characterization of a new SCC antigen producing cell line (HCS-2) from a carcinoma of the uterine cervix].
Morisawa T; Kuramoto H; Shimoda T; Sakamoto I; Kato Y; Hamano M
Hum Cell; 1988 Sep; 1(3):308-14. PubMed ID: 2979208
[TBL] [Abstract][Full Text] [Related]
45. [Squamous cell carcinoma (SCC)--nature and usage in patients with cervical carcinoma].
Bocheva Y; Bochev P; Chaushev B; Ivanov S
Akush Ginekol (Sofiia); 2015; 54(2):29-34. PubMed ID: 25909138
[TBL] [Abstract][Full Text] [Related]
46. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Nishino T; Saito J; Abe Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):919-22. PubMed ID: 3894536
[TBL] [Abstract][Full Text] [Related]
47. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix.
Crombach G; Scharl A; Vierbuchen M; Würz H; Bolte A
Cancer; 1989 Apr; 63(7):1337-42. PubMed ID: 2920361
[TBL] [Abstract][Full Text] [Related]
48. SCC tumour marker and its relationship to clinical stage in squamous cervical cancer.
Henry RJ; Dodd JK; Tyler JP; Houghton CR
Aust N Z J Obstet Gynaecol; 1987 Nov; 27(4):338-40. PubMed ID: 3453675
[TBL] [Abstract][Full Text] [Related]
49. Isoantigen loss in cervical neoplasia. Demonstration by immunofluorescence and immunoperoxidase techniques.
Bonfiglio TA; Feinberg MR
Arch Pathol Lab Med; 1976 Jun; 100(6):307-14. PubMed ID: 57765
[TBL] [Abstract][Full Text] [Related]
50. Prognostic value of squamous cell carcinoma antigen in patients with uterine cervical carcinoma.
Bhatavdekar JM; Ghosh N; Shukla MK; Balar DB; Bhaduri A; Karelia NH; Shah NG; Trivedi SN
Tumori; 1988 Apr; 74(2):221-5. PubMed ID: 3368976
[TBL] [Abstract][Full Text] [Related]
51. Factors regulating SCC antigen expression in squamous cell carcinoma of the uterine cervix.
Maruo T; Yoshida S; Samoto T; Tateiwa Y; Peng X; Takeuchi S; Motoyama S
Tumour Biol; 1998; 19(6):494-504. PubMed ID: 9817979
[TBL] [Abstract][Full Text] [Related]
52. Role of squamous cell carcinoma antigen in prognostication, monitoring of treatment response, and surveillance of locally advanced cervical carcinoma.
Tony V; Sathyamurthy A; Ramireddy JK; Iswarya SJ; Gowri SM; Thomas A; Peedicayil A; Ram TS
J Cancer Res Ther; 2023; 19(5):1236-1240. PubMed ID: 37787289
[TBL] [Abstract][Full Text] [Related]
53. Production and characterisation of a monoclonal antibody (Cx-99) against cervical carcinoma.
Yuan CC; Tsai LC; Hsu SC; Ng HT; Tsai SJ; Chen HM; Hung MW; Ho CK; Ho DM; Gill TJ
Br J Cancer; 1992 Feb; 65(2):201-7. PubMed ID: 1739618
[TBL] [Abstract][Full Text] [Related]
54. The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis.
Charakorn C; Thadanipon K; Chaijindaratana S; Rattanasiri S; Numthavaj P; Thakkinstian A
Gynecol Oncol; 2018 Jul; 150(1):190-200. PubMed ID: 29606483
[TBL] [Abstract][Full Text] [Related]
55. A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma.
Gadducci A; Ferdeghini M; Prontera C; Giordano P; Cristofani R; Bianchi R; Fioretti P
Eur J Gynaecol Oncol; 1990; 11(4):283-8. PubMed ID: 2245812
[TBL] [Abstract][Full Text] [Related]
56. Utility of squamous cell carcinoma antigen (SCC Ag) as a tumour marker in pulmonary malignancy.
Upham J; Campbell B
Respir Med; 1992 May; 86(3):201-3. PubMed ID: 1620906
[TBL] [Abstract][Full Text] [Related]
57. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation.
Kato H; Nagaya T; Torigoe T
Gan; 1984 May; 75(5):433-5. PubMed ID: 6745563
[TBL] [Abstract][Full Text] [Related]
58. Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin.
Duk JM; van Voorst Vader PC; ten Hoor KA; Hollema H; Doeglas HM; de Bruijn HW
Cancer; 1989 Oct; 64(8):1652-6. PubMed ID: 2790678
[TBL] [Abstract][Full Text] [Related]
59. Squamous-cell carcinoma antigen (SCC-A) values related to clinical outcome of pre-invasive and invasive cervical carcinoma.
Brioschi PA; Bischof P; Delafosse C; Krauer F
Int J Cancer; 1991 Feb; 47(3):376-9. PubMed ID: 1704354
[TBL] [Abstract][Full Text] [Related]
60. Squamous cell carcinoma (SCC) antigen in patients with invasive cervical carcinoma during primary irradiation.
Neunteufel W; Tatra G; Bieglmayer C
Gynecol Obstet Invest; 1990; 29(2):154-7. PubMed ID: 2335313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
